echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > Does neuroinflammation contribute to Alzheimer's disease?

    Does neuroinflammation contribute to Alzheimer's disease?

    • Last Update: 2021-09-13
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    "Nature-Medical" magazine recently published a new study on Alzheimer's disease, suggesting that neuroinflammation is the main factor that leads to the spread of key pathological proteins in the brain and drives the development of cognitive impairment
    .

    Researchers at the University of Pittsburgh School of Medicine used real-time imaging to find evidence in the brains of living patients for the first time, showing that neuroinflammation is not just a consequence of disease progression, but a key upstream mechanism of disease development
    .

    Neuroinflammation is a major feature of the brains of patients with Alzheimer's disease
    .


    One of the important signs is that the immune cells residing in the brain, microglia, appear to be activated


    Previously, researchers have obtained a lot of evidence from cells and animals cultured in the laboratory, showing that the activation of microglia promotes the spread of tau protein fibrillary tangles, and the tau protein fibrillary tangles formed in nerve cells are Alzheimer's disease One of the key pathological features
    .

    This study further examined the relationship between the activation of microglia in the human brain and the spread of tau protein throughout the cerebral cortex and the occurrence of cognitive impairment
    .

    Researchers used positron emission tomography brain imaging to analyze the brains of 130 elderly patients of different ages and at different stages of Alzheimer’s disease, as well as the brains of healthy elderly people, and examined their microglia activation, two key points Pathological protein β-amyloid deposition and tau protein tangles
    .


    In addition, the researchers also assessed the concentration of TREM2 in the cerebrospinal fluid of these participants.


    They observed that neuroinflammation is more common in older older adults, and is more pronounced in patients with mild cognitive impairment and Alzheimer's disease-related dementia
    .

    ▲The degree of neuroinflammation in the brains of patients with Alzheimer's disease is higher than that in healthy elderly people (picture source: reference [2]; Credit: Adapted from Pascoal et al.
    , Nature Medicine)

    A number of bioinformatics analyses have shown that the diffusion path of tau protein depends on the activation of microglia-the latter is a key factor that links the effect of beta amyloid deposit plaques with the spread of tau protein and cognitive impairment
    .


    The simultaneous occurrence of β-amyloid, tau and microglia abnormalities is the strongest predictor of cognitive impairment


    The researchers pointed out that targeting neuroinflammation for treatment will benefit patients with early Alzheimer's disease, and may help delay or even reverse the accumulation of pathological tau protein and avoid disease progression


    Reference materials:

    [1] Tharick A.


    [2] Brain tissue inflammation is key to Alzheimer's disease progression.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.